Nicholas A. Saccomano Ph.D.
Chief Executive Officer, OnKure Therapeutics
Nicholas A. Saccomano is currently the CEO of OnKure therapeutics, a precision oncology company in Boulder Colorado. He is a…
Nicholas A. Saccomano is currently the CEO of OnKure therapeutics, a precision oncology company in Boulder Colorado. He is a…
Deborah Palestrant, Ph.D., M.B.A. joined 5AM Ventures in 2018 and is a Partner and Executive Chair of 4:59 Initiative. She…
Named by Time as one of the 50 most influential people in healthcare in 2018, Dr. Harper has helped bring…
Hyung is a seasoned physician-scientist who joined Foresite Capital in 2021 after being a member of the faculty at Yale…
Nancy Stagliano, Ph.D., is CEO and chair of the board of Neuron23, Inc., a clinical-stage biotechnology company focused on developing…
Desmond has more than 20 years of experience developing drugs across multiple therapeutic areas and brings a wealth of experience…